BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, May 29, 2026
Home
»
Authors
»
Nuala Moran
Articles by Nuala Moran
Government Helps London Centers Spin Off Companies
March 7, 2001
By
Nuala Moran
PPL Says Disease In UK Should Not Affect Clones
March 7, 2001
By
Nuala Moran
GlaxoSmithKline Adopts Biotech Business Model, Creates Six Units
Feb. 28, 2001
By
Nuala Moran
Xenova On Track To Partner XR9576 Following Phase II
Feb. 28, 2001
By
Nuala Moran
MVM Raising £40M To Invest In Young U.S., UK Companies
Feb. 28, 2001
By
Nuala Moran
GlaxoSmithKline Adopts Biotech Business Model, Creates Six Units
Feb. 28, 2001
By
Nuala Moran
Xenova On Track To Partner XR9576 Following Phase II
Feb. 28, 2001
By
Nuala Moran
MVM Raising £40M To Invest In Young U.S., UK Companies
Feb. 28, 2001
By
Nuala Moran
Xenova, Cantab Merging Via All-Stock Deal Valued At £124
Feb. 21, 2001
By
Nuala Moran
Cyclacel Moves Oral CDK Inhibitor Into Human Trials
Feb. 21, 2001
By
Nuala Moran
Previous
1
2
…
530
531
532
533
534
535
536
537
538
539
540
Next